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ABSTRACT
 As fermented soybean (Glycine max), tempeh has been reported as a good source of 
isoflavones, which have shown anticancer activities in various cancer cells resulted from their activity 
as phytoestrogens. In this article, the preparation of ethanolic extract of tempeh is presented and 
then followed by the exploration of its cytotoxic effect on T47D cells. The extract was subsequently 
standardized using genistein, the major phytoestrogen found in tempeh. The genistein concentration 
found in the extract of tempeh was 0.681 % (w/w). The cytotoxicity assay employing 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) resulted in IC50 values of 196.066 ± 
15.956 µg/mL and 13.174 ± 0.905 µg/mL for the genistein-standardized ethanolic extract of tempeh 
and genistein, respectively. 
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INTRODUCTION
 Soybean (Glycine max (L.) Merr.) has 
been consumed for centuries and widely known as 
dietary sources for isoflavones, especially in many 
Asian countries1,2.Soyfoods intake was associated 
with lower risk of breast and prostate cancer1,3 and 
coronary heart disease independent on cholesterol 
and fracture effects1. Moreover, a high soy diet 
showed memory improvement, which could be 
associated with activities of  histone deacetylases 
(HDACs)3,4. Similar to other phytoestrogens, 
the isoflavones from soybean have activities in 
cancer cells resulted from their activity as ligands 
for estrogen receptors2,5,6, a biomarker of breast 
cancer7–9.Notably, genistein is the most popular 
studied  isoflavones and has been used as the 
reference ligand for estrogen receptors, both 
estrogen receptor a (ERa)and estrogen receptor b 
(ERb) 10,11. 
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 Tempeh, one of the fermented soy products, 
has been widely known as a good resource of 
isoflavones2,12. The structures of 12 isoflavones 
commonly found in tempeh are presented in Figure 
11,12–14. Compared to soy flavor and other soyfoods, 
i.e., soy flavor, tofu, texturized vegetable protein, and 
soy germ, tempeh contains the highest concentration 
of genistein12. The activity of soyfoods in lowering 
cancer risk of tempeh was also associated with the 
activity of genistein in inhibiting the activity of tyrosine 
protein kinase, an overexpressed enzyme in many 
cancer cells1,15,16.
 The research presented in this article aimed 
to investigate the potency of ethanolic extract from 
tempeh to be developed as an herbal medicine 
for cancer chemoprevention. The preparation of 
ethanolic extract of tempeh and the subsequently 
standardization of the extract by analyzing the 
concentration of phytochemical genistein are 
presented in this article13,14,17–19. The cytotoxic activity 
on T47D cells of the genistein-standardized ethanolic 
extract of tempeh was evaluated and compared to 
genistein as the reference compound20,21. 
MATERIALS AND METHODS
 Tempeh was collected from local market 
in Yogyakarta, Indonesia. Genistein and 3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium 
bromide (MTT) were purchased from Sigma-Aldrich. 
Petroleum ether and ethanol for extraction, methanol, 
ethyl acetate, and dimethyl sulfoxide (DMSO) 
were purchased from Merck and distilled water 
was purchased from PT. Ikapharmindo Putramas 
(Indonesia). All solvents were at least of analytical 
grade or distilled before being used. The T47D 
cell line was cultured in Parasitology Laboratory, 
Faculty of Medicine, Universitas Gadjah Mada, 
Yogyakarta, Indonesia. Dulbecco’s Modified Eagle 
Media (DMEM) as medium was supplied by Gibco(R) 
while phosphate-buffered saline (PBS) 10% and 
sodium dodecyl sulfate(SDS) 10% were provided 
by Parasitology Laboratory, Faculty of Medicine, 
Universitas Gadjah Mada, Yogyakarta, Indonesia. 
Sodium duodecyl sulphate as stopper reagent was 
obtained from Merck.
Preparation of ethanolic extract of tempeh 
and determination of genistein content in the 
ethanolic extract
 One kg of tempeh was blended and 
macerated in petroleum ether 1:1 for 40 minutes and 
the petroleum ether was subsequently removed. For 
maceration, ethanol 96% was added and the mixture 
was shaken at 150 rpm for 12 hours.  The brown 
colored residue was removed and the liquid phase 
was evaporated using rotary evaporator for 45- 60 
minutes leaving 10% extract volume compared from 
the initial volume. Viscous extract was dried at 50°C in 
an oven up to a constant weight. The ethanolic extract 
was then fractionated using water and ethyl acetate. 
Fig. 1: Structures of isoflavones found in tempeh12
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Table 1: Effect Of The Ethanolic Extract Of Tempeh And Genistein 
On T47D Cell Viability After Incubation For 24 Hours
Concentration (µg/mL) Percentage of T47D viability  IC50 (µg/mL)
Ethanolic Extract of Tempeh: (mean ± standard deviation) (mean ± standard deviation)
103 0.03 ± 0.49  196.066 ± 15.956a
102 90.52 ± 1.54 
10 98.89 ± 5.13 
1 102.84 ± 5.62 
10-1 99.65 ± 2.45 
10-2 101.76 ± 5.62 
10-3 100.59 ± 4.38 
Genistein:
270.237 x 100 1.42 ± 0.49 13.174 ± 0.905b
270.237 x 10-1 23.99 ± 0.71 
270.237 x 10-2 88.08 ± 3.75 
270.237 x 10-3 87.05 ± 1.90 
270.237 x 10-4 96.81 ± 2.80 
270.237 x 10-5 99.21 ± 6.06 
270.237 x 10-6 98.23 ± 1.17 
aR2 of the logistic regression model = 0.949; bR2 of the logistic regression model = 0.990
Fig. 2: Representative chromatogram of the ethanolic extract from tempeh. Column: 
Phenomenex® C18 column, 250 x 4.6 mm. Mobile phase: methanol-aquabidest (70:30). Flow rate: 
0.7 mL/min. Detection at 261 nm
The ethyl acetate was subsequently evaporated in 
water bath and dried until its weight was constant.
 One mg of genistein as the standard was 
accurately weighed into a vial and dissolved in 1.0 mL 
ethanol. A series of genistein solutions was prepared 
by transferring standard genistein solution into 5 mL 
volumetric flask for each concentration and dilute 
to volume with ethanol to have concentrations as 
followed: 1.813, 3.626, 5.438, 7.250, 9.063, 10.876, 
14.501, 18.126 mg/mL. Into 200 mL of ethanol, 
7.3319 g of the ethanolic extract was dissolved. 
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Ten µL of the solution was added ethanol up to 5.0 mL 
and was then filtered by using Millipore membrane 
0.45 µm which was degassed before injection.All 
samples solutions were analyzed using Shimadzu 
LC-2010 high performance liquid chromatography 
(HPLC) with UV detector. The analytical column 
was a Phenomenex®C18 column No. 00G-4252-E0 
(250 x 4.6 mm). Chromatography was carried out 
using methanol-redistilled water 70:10 (v/v) as the 
mobile phase. The flow rate of the mobile phase was 
maintained at 0.7 mL/min in the isocratic reverse-
phase HPLC system19. The injection volume was 
10 µL. Genistein content in the ethanolic extract 
was measured at UV 261 nm. All instruments were 
controlled via the software platform LabSolution 
originated from Shimadzu LC-2010 HPLC.
MTT cytotoxic assay22,23
 The T47D cells20 were sub cultured until 
confluent then 104 cells were seeded into 96-well 
microplate and incubated in 37oCequipped with 5% 
CO2 for 24 hours. DMEM medium was removed 
and rinsed with PBS 10% before the ethanolic 
extract of tempeh and genistein were dissolved in 
DMSO as stock. The allowed final concentration of 
DMSO as cytotoxic solvent used in this research 
was maximum 5%.The various concentrations 
of the ethanolic extract of tempeh and genistein 
in DMEM medium were added into 96-well plate 
100 µL each and incubated in 37 oC and 5% CO2 
for 24 hours. Each concentration was assayed in 
triplicates (n=3). The DMEM medium culture was 
removed and rinsed by PBS 10%. Subsequently, 
a hundred µL DMEM containing 5 mg/mL of 
MTT was added into each well and incubated for 
4 hours. Further, medium containing MTT was 
removed and 100 µL of SDS 10% was added to 
each well to dissolve formazan crystal. The 96-well 
plate was incubated for 24 hours in a dark room to 
avoid contact with light. Formazan crystals were 
then detected by ELISA reader using wavelength 
of 595 nm. The IC50 values were calculated using 
four parameters logistic regression by employing R 
computational statistics software version 3.1.323–25 
with constrained slope value of 3.00.
  
RESULTS AND DISCUSSION
 The research aimed to investigate the 
potential of ethanolic extract from tempeh as an 
herbal medicine for breast cancer chemoprevention. 
Similar to Song and Barua14, tempeh used in this 
research was obtained from local market. Since 
there is no standardization of tempeh production, 
the ethanolic extract of tempeh was standardized 
by analyzing the concentration of genistein in the 
corresponding extract12–14. Genistein in soy has been 
accurately analyzed using reverse phase HPLC 
method12–14,19,26, which was therefore applied here to 
determine genistein concentration in the ethanolic 
extract.
 The extraction resulted in 27 g (2.7 % 
w/w) of the ethanolic extract of tempeh. Isocratic 
chromatography was carried out using methanol-
redistilled water 70:10 (v/v) as the mobile phase. 
The peak of genistein was found at retention time 
7.350 min (Figure 2). The absorbance data versus 
concentration of genistein was treated using linear 
correlation coefficient. The following is the calibration 
curve equation of genistein standard resulted from 
the linearity test: y = 33857.0x – 3508.4 with r 
value of 0.9999. Employing the equation, genistein 
concentrations in the ethanolic extract can be 
calculated by examining the area under curve 
(AUC) resulted from the HPLC. The AUC values 
were 162932,169496, 164290, 166596, 164778 
and 164991, which corresponded to the genistein 
concentrations of 245.799, 255.493, 247.805, 
251.210, 248.525 and 248.840 µg/mL, respectively. 
Therefore, it can be concluded that the mean ± 
standard deviation of genistein found in the ethanolic 
extract of tempeh used in this research was 249.612 
± 0.003 µg/mL. Since the initial weight of the sample 
was 7.3319 g, the concentration of genistein in 
the ethanolic extract was 0.681 % (w/w). Notably, 
another major peak at the retention time of 6.098 min 
was emerged in the chromatogram of the ethanolic 
extract (Figure 2). 
 Tempeh was selected since it contains 
the highest concentration of genistein12,14 and 
as fermented product of soybean it has higher 
concentration of aglycon isoflavones compared 
to the seed14. The results showed that genistein 
concentration in the ethanolic extract was 0.681 
% (w/w), which wasapproximately 7-folds higher 
than the total genistein concentration in tempeh, 
which was extracted for 2 hours using ethanol and 
dried using evaporator in temperature of less than 
1623YULIANI et al., Orient. J. Chem.,  Vol. 32(3), 1619-1624 (2016)
30 oC reported by Murphy et al.12. The differences 
in the extraction process were therefore suggested 
resulting in multiple higher genistein concentration 
in this study since the present extraction of tempeh 
were longer (12 hours) whereas the drying process 
was using higher temperature (50 oC)12,14. This result 
confirms that the ethanolic extract of tempeh could 
be a good source of aglycon isoflavones, especially 
genistein1,2,16. Notably, in the chromatogram 
presented in Figure 2, another major peak at the 
retention time of 6.098 min was emerged. This 
peak is suggested belongs to daidzein, which was 
reported as another major compound in tempeh 
that could be detected using C18 column in reverse 
HPLC with smaller retention time than genistein13,27. 
Daidzein and genistein were reported as potent 
ligands for estrogen receptors6.
 After the concentration of genistein in the 
ethanolic extract has been determined, its cytotoxic 
activity against T47D cell line was subsequently 
evaluated and compared to the cytotoxic activities 
of genistein11,21,28. The results are presented in Table 
1. The results showed that the IC50 value of the 
ethanolic extract was 196.066 ± 15.956 µg/mL, while 
the IC50 value of genistein was 13.174 ± 0.905 µg/
mL. Since genistein concentration in the ethanolic 
extract was only 0.681 % (w/w), other components 
in the extract especially other isoflavones could also 
play an important role in the cytotoxic activity of the 
ethanolic extract against T47D cell line1,11,16.
 The ethanolic extract of tempeh is 
therefore a good source to be developed as the 
active ingredients in herbal medicines for breast 
cancer chemoprevention. There was evidence that 
orally administered tamoxifen for breast cancer 
treatment showed severe adverse effects29,30, 
which could be significantly reduced by transdermal 
administration30,31. Therefore, development topical 
dosage forms containing ethanolic extract of 
tempeh that could deliver the aglycone isoflavones 
through the skin for cancer chemoprevention is of 
considerable interest. Notably, although tempeh 
is considered as safe, further investigation to 
determine the safety of the ethanolic extract should 
be performed.32
CONCLUSIONS
 The ethanolic extract of tempeh, a 
fermented product of soybean contains 0.681 
% (w/w) genistein. The cytotoxic assay on T47D 
breast cancer cell of the extract and genistein as the 
reference using MTT method resulted in IC50 values 
of 196.066 ± 15.956 µg/mL and 13.174 ± 0.905 µg/
mL, respectively. The ethanolic extract of tempeh 
could therefore serve as the active ingredients in 
cancer chemoprevention
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